Bioorganic and Medicinal Chemistry Letters p. 2677 - 2682 (1996)
Update date:2022-08-02
Topics:
Friesen, Richard W.
Dube, Daniel
Fortin, Rejean
Frenette, Richard
Prescott, Sylvie
Cromlish, Wanda
Greig, Gillian M.
Kargman, Stacia
Wong, Elizabeth
Chan, Chi Chung
Gordon, Robert
Xu, Li Jing
Riendeau, Denis
A series of novel 2,3-diaryl-2-cyclobuten-1-ones have been synthesized and have been evaluated with respect to their ability to inhibit the isozymes of cyclooxygenase, COX-1 and COX-2. 4,4-Dimethyl-2-phenyl-3-[4-(methylsulfonyl)phenyl]cyclobutenone 22 was found to be highly selective for inhibition of COX-2 and was orally active (ED50 = 2.4 mg/kg) in the rat paw edema model.
View MoreSuZhou Bichal Biological Technology CO.,LTD
Contact:+86-512-68051130
Address:NO.32 huoju road HI-TECH Industrial development zone SuZhou China
Contact:+33-5-34012600
Address:28 ZA des Pignès
AllyChem Co., Ltd., Dalian, China（BBChem）
Contact:+86-411-62313318/62313328
Address:No.5 of Jinbin Road, Jinzhou New District, Dalian City, Liaoning Province, P.R.China
SuZhou Hua-Emy Chemical Import and Export Co., LTD.
Contact:+86-512-88804994; +86-512-88804550;
Address:710, Building B, International Trade Center, 12 Huanghelu, Changshu, Jiangsu,China
Shanghai Dano Pharmaceutical Co.,Ld.(expird)
Contact:+86-592-6266840
Address:Building 1 Room 512, 720 Cailun Rd, Zhangjiang High-Tech Park, Shanghai 201203, China
Doi:10.1016/S0960-894X(96)00561-6
(1996)Doi:10.1002/cctc.201601654
(2017)Doi:10.1002/anie.199701551
(1997)Doi:10.1016/S0040-4039(96)02196-X
(1997)Doi:10.1002/chem.19970031006
(1997)Doi:10.3797/scipharm.aut-04-02
(2004)
